Although insulin deficiency and insulin resistance are implicated in the development and progression of bone loss, studies elucidating the effects of insulin treatment on bone health yielded heterogeneous outcomes, either having beneficial or negligible effects [26,37]. The gene discussed is INS; the disease is Insulin resistance.